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Case Report
In June 2000 a mercury spill occurred aboard
an iron ore carrier in an unventilated steel stor-
age compartment measuring approximately
10 ft × 10 ft × 30 ft. The compartment was
located above the boiler, so the ﬂoor tempera-
ture varied from 105°F when in dock to as
much as 130°F when the ship was underway.
The ceiling of the storeroom was the upper
deck, and the walls were steel with a tight-
ﬁtting steel door at one end (Figure 1). Within
this enclosed compartment, two maritime
academy interns (referred to in this report as
interns X and Y) were working on supply
inventory. Intern X started his inventory in the
storeroom farthest from the door. He opened a
drawer to ﬁnd approximately 40 lb of mercury
stored in a polyethylene bottle with a screw-
top lid. Unaware of its weight, he dropped the
bottle onto the ﬂoor, spilling a portion of the
metal across the floor as well as splashing it
onto his coveralls and into his boots. He was
aware that his coveralls were contaminated,
but he claimed he did not realize that the
inside of his boots were also contaminated.
Intern Y was working at the opposite end of
the storeroom, nearest the door. The incident
was not reported immediately; both interns
continued to work for 3 days in the storeroom
after the spill occurred, completing their inven-
tory. Both showered the day of the spill but
continued to work in contaminated coveralls.
After their inventory was completed, the
interns notiﬁed the chief engineer of the spill.
The chief engineer conﬁscated and discarded
the contaminated coveralls, immediately
cleaned the exposed area with a sulfur amal-
gam compound according to Occupational
Safety and Health Administration (OSHA)
protocol (Lawrence Livermore National
Laboratory 2001), and secured the store-
room, allowing no further access until the
ship docked and the storeroom was deconta-
minated. Medical and personnel authorities
were notified when the chief engineer was
informed of the spill. Serum mercury levels of
the interns were ordered as they left the ship.
Intern Y was assigned to another ship and did
not have his serum drawn until the second
ship docked. Intern X felt he had the “flu”
and decided to take his vacation, so he left for
home. He continued wearing his boots and
possibly contaminated socks, but his other
clothing was conﬁscated and discarded by the
chief engineer.
Intern Y reported feelings of lethargy,
headaches, lightheadedness, and excessive
thirst that lasted for several days aboard the
second ship. These symptoms resolved by the
time the second ship arrived at port and he
had his serum tested. Two mercury levels
were evaluated. His ﬁrst serum level, obtained
15 days after the initial exposure, was
4 ng/mL; the range in the general population
is 0–9 ng/mL, and a serum level of 50 ng/mL
is considered toxic (Mayo Clinic 2002). He
reported complete resolution of his symptoms
at the time his serum was drawn 19 days after
initial exposure. At that time, his mercury
level was < 0.05 ng/mL; his serum creatinine
of 1.4 mg/dL was not considered sufﬁciently
abnormal with respect to his mercury levels to
warrant reevaluation. Intern Y was examined
by R.R.R. 17 days after the initial exposure
and was found to have no mental status
changes, ataxia, tremor, or protein in his urine.
Intern X, who had spilled the mercury,
reported symptoms of fatigue, drowsiness, and
trouble sleeping when his mercury level was
11 ng/mL. Eleven days after the initial expo-
sure his level had risen to 56 ng/mL. A third
test 15 days after the initial exposure showed
an increase to 89 ng/mL. At this point, Intern
X’s mother reported by telephone conversa-
tion that he was “nervous and tremulous.” She
was advised to seek medical attention for her
son immediately. He was seen by his primary
physician and admitted to the hospital
16 days after the initial exposure; his mercury
level was 188.8 ng/mL. Upon admission to
the hospital, the nurse took off his footwear,
including the boots, which she reported was
visibly contaminated with mercury. Intern X
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Two maritime academy interns (X and Y) were exposed to mercury vapor after spilling a bottle of
mercury on the ﬂoor in an enclosed storeroom while doing inventory aboard an ore boat. During
a 3-day period, intern Y suffered transient clinical intoxication that resolved after he was
removed from the environment and he showered and discarded all clothing. His initial serum
mercury level dropped from 4 ng/mL to < 0.05 ng/mL. Intern X had an initial level of 11 ng/mL,
which continued to rise to a maximum of 188.8 ng/mL. He complained of tremulousness,
insomnia, and mild agitation and was hospitalized. He had showered and discarded all clothing
except his footwear earlier than intern Y. Intern X’s continued exposure due to mercury in the
contaminated boots during the 2 weeks before hospitalization was presumed to be the cause.
Removing his footwear led to resolution of his toxic symptoms and correlated with subsequent
lowered serum mercury levels. Chelation was initiated as recommended, despite its uncertain ben-
eﬁt for neurologic intoxication. Mercury is used in the merchant marine industry in ballast moni-
tors called king gauges. New engineering is recommended for ballast monitoring to eliminate this
hazard. Key words: ballast gauge, chelation therapy, dimercaptosuccinic acid, mercury intoxication,
neurotoxicity. Environ Health Perspect 112:910–913 (2004). doi:10.1289/ehp.6798 available via
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Environmental Medicine Grand Roundshad been wearing the boots daily since the ini-
tial exposure. It is not known from the record
whether he had consistently worn socks or
whether he changed socks. The toxicologist,
consulted by his primary physician, reported
to one of us (R.R.R.) that the boots were not
analyzed but were “contaminated with visible
mercury.”
Seventeen days after the initial exposure,
while Intern X was in the hospital, a 24-hr
urine collection revealed a mercury level of
356 µg/L and creatinine of 1.2 mg/dL. Liver
function studies were normal. Chelation ther-
apy was initiated with succimer, 700 mg
orally every 8 hr for 5 days, and then every
12 hr for another 14 days. His blood pressure
was normal, and his initial creatinine level
was 1.1 mg/dL (17 days after the initial expo-
sure) rising to 1.3 mg/dL 11 days after hospi-
talization before normalizing at 0.9 mg/dL
21 days after hospitalization. Intern X’s serum
mercury levels drawn 21 days and 38 days
after the initial exposure were 182 ng/mL and
17 ng/mL, respectively. By 2 months after the
initial exposure, his levels were < 0.5 ng/mL
(Figure 2).
Although Intern X described tremulous-
ness, no tremor or ataxia was noted by the
attending physician, even though he specifi-
cally looked for them. The clinician found no
alteration of mental status, and neuropsycho-
logic testing was not performed. A neurologist
was not consulted because the symptoms were
improving and the toxicologist with the pri-
mary internist had begun chelation therapy.
One of us (R.R.R.) assessed the patient before
he returned to his maritime duties and found
no cognitive impairment, tremor, abnormalities
of reﬂexes, or ataxia.
Environmental Testing
Mercury vapor readings were assessed by a cer-
tified industrial hygienist, as described by
Norman (2000), with a Jerome model 431-X
mercury vapor analyzer (Certified Industrial
Hygienist Services, Duluth, MN) that can
detect mercury concentrations as low as
0.001 mg/m3. The American Conference of
Governmental Industrial Hygienists deﬁnes a
concentration of 0.025 mg/m3 as the threshold
limit value (OSHA 2004) for an 8-hr time-
weighted average limit for toxic exposure.
OSHA (2004) uses 0.10 mg/m3 as the permis-
sible exposure limit. Mercury level readings
were obtained throughout the storage com-
partment (Figure 1). Inside the locker of the
storage compartment where the mercury was
kept, the mercury levels were 0.999 mg/m3
(maximum meter reading). Measurements
taken in the interns’ quarters were 0.012 and
0.025 mg/m3. The lower reading was in intern
Y’s bunk, and the higher reading was recorded
in intern X’s bunk. A reading of 0.025 mg/m3
was recorded in the shower area.
Because the engine control room and the
captain’s bridge were the locations of the king
gauges, measurements were also made in
those two areas. In the engine control room, a
level of 0.015 mg/m3 was detected under the
king gauge and at the engine control panel.
Just above the reservoir, a mercury level of
0.024 mg/m3 was detected. On the captain’s
bridge near the captain’s chair, the reading
was undetectable. However, above the carpet
under the gauge where there was visible liquid
mercury, a level of 0.006 mg/m3 was found,
whereas above the capped reservoir the mer-
cury level was 0.028 mg/m3. Significantly,
these areas were air conditioned to below
70°F. Measurements for mercury were also
taken in the food processing areas, dining
room elevator, engineer’s quarters, random
cabins of other officers and sailors, and the
hallways leading to the interns quarters. All
these readings were at undetectable levels.
After the decontamination procedure,
readings of 0.000–0.003 mg/m3 in the stor-
age compartment documented adequate
removal of the mercury vapor source. The
drawer where the mercury container was
stored registered 0.007 mg/m3. Levels in the
interns’ quarters were undetectable, and levels
under the king gauges after cleanup were
0.004 mg/m3 in the engine control room and
0.013 mg/m3 on the captain’s bridge.
Discussion
Mercury has been used for industrial and
medicinal purposes for several millennia
(Sunderman 1988). Although most medicinal
use of mercury has been discontinued, cultural
use (Wendroff 1995) and industrial use of mer-
cury are ongoing (Agocs et al. 1992; Ozuah
2000). In 2001, the American Association of
Poison Control Centers reported a total of
3,550 cases of mercury exposure in the United
States (Litovitz et al. 2001). Occupational
exposure, now the principal source of mercury
intoxication, typically results from improper
handling of mercury, accidental spills, and
poor ventilation in the work environment
(Ozuah 2000). Elemental mercury vapor
accounts for most of those reported cases
(Agocs et al. 1992).
U.S. Steel Great Lakes Fleet shipping
companies use king gauges extensively for
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Figure 1. Diagram of the storeroom where the spill occurred. The levels of mercury vapor are shown
where they were recorded in the storeroom.
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Figure 2. Diagram of the serum levels of the two interns.
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0 4 0.5determining the ballast necessary to keep the
ship balanced during loading of iron ore,
grain, and limestone. The king gauge is a
labeled row of parallel upright mercury-ﬁlled
half-inch-diameter glass columns. Each col-
umn reflects the ballast in one of compart-
ments of the ship’s hold. Although each
mercury-filled column is capped, small
amounts of mercury can spill out of the col-
umn or vaporize. The ship carries a supply of
mercury in order to refill the columns when
they reach a minimum threshold. Frequently,
small amounts of mercury are found on the
ﬂoor under the gauge. The two king gauges on
the ship are on the bridge and in the engine
control room.
Elemental mercury is poorly absorbed
through the skin at a rate of 0.025 mg/m3
(OSHA 2004). Only 0.01% of mercury is
absorbed through the gastric mucosa after
ingestion (Agocs et al. 1992; Ozuah 2000).
However, when elemental mercury is vapor-
ized, it is 80% absorbed (Agocs et al. 1992)
through alveolar membranes and distributes
into red blood cells and tissue (Centers for
Disease Control and Prevention 1991). About
7–14% of inhaled mercury is exhaled within a
week after exposure (U.S. EPA 1997). Once
absorbed, mercury diffuses throughout the
body, concentrating in the liver, kidneys, and
brain. Diffusion of the metal across the
blood–brain barrier can result in irreversible
damage to the central nervous system
(Bradberry and Vale 2001), including the
cerebellum (Florentine and Sanﬁlippo 1991).
The major route of excretion (90%) of
mercury is through bile into the feces. Urine
accounts for another 10% of the elimination
process (Agocs et al. 1992). Renal storage sig-
nificantly lowers serum levels acutely once
exposure has ceased (Maiorino et al. 1996),
but the elimination of mercury through biliary
and urinary excretion is a slow process, with a
half-life in excess of 40 days (Ozuah 2000).
Therefore, elimination of the source is the pri-
mary approach to therapy. Chelation therapy,
used since the 1950s, is based on the concept
of chemically binding the metal and promot-
ing its urinary excretion (Bruno 1999;
Frumkin et al. 2001). Dimercaptosuccinic
acid (DMSA) is considered the safest, most
effective treatment for mercury poisoning
(Aaseth et al. 1995), but it apparently does not
affect mercury retained in the brain (Kostial
et al. 1997). Polythiol, a nonabsorbable resin,
can aid in removal by binding mercury in
excreted bile (Cikrt and Lenger 1980).
Although in common use, these therapies have
yet to be approved by the Food and Drug
Administration.
The value of chelation therapy after
inorganic or elemental mercury exposure
remains controversial. Several studies have
documented that DMSA treatment results in
increased urinary excretion of mercury (Roels
et al. 1991; Torres-Alanis et al. 1995). In a ran-
domized, double-blind, parallel group design
study with oral administration of DMSA or a
placebo for 14 days, Englund et al. (1994)
demonstrated an increase in mercury excretion,
but there was no evidence that chelation ther-
apy alleviated neurologic symptoms in the
study. Studies such as these question whether
excretion equals efﬁcacy in resolving toxicity
(Kosnet 1992; Kostial et al. 1997). According
to other researchers, there is no evidence that
chelation removes mercury from the brain
(Buchet and Lauwerys 1989; Louwerse et al.
1995; Nierenberg et al. 1998). Several studies
report that chelation increases urinary excre-
tion of mercury (Buchet and Lauwerys 1989;
Goyer et al.1995; Louwerse et al. 1995; Roels
et al. 1991; Torres-Alanis et al. 1995). A con-
trolled animal study of rats exposed to mercury
vapor with subsequent administration of
chelating agents demonstrated that chelators
mobilize mercury only from the kidneys and
not from the brain (Buchet and Lauwerys
1989). Chelation did not effect brain levels,
even with increasing doses of chelator.
Mercury poisoning can cause a nonfocal
permanent encephalopathy (Bradberry and
Vale 2001). Acute exposure to elemental mer-
cury vapor is characterized by euphoria, irri-
tability, anxiety, and emotional lability,
whereas chronic exposure results in mental
confusion, altered level of consciousness, and
permanent tremor (LaDou 1997; Letz et al.
2000) or cerebellar ataxia (Cherry et al. 2002).
Acute exposure to mercury affects the pul-
monary, renal, and nervous systems. Initial
evaluation of the patient with acute inhala-
tion of mercury vapor, according to LaDou
(1997), should address the potential for
cyanosis, tachypnea, and pulmonary edema;
therefore, arterial blood gas measurement and
a chest X ray are important if respiratory
symptoms are present. Gastrointestinal symp-
toms of nausea, vomiting, and diarrhea are
not usually life threatening. Renal injury pre-
sents with a diuretic phase and then pro-
teinura and can result in renal failure.
Neuropsychiatric manifestations include
symptoms of agitation, anxiety, and tremu-
lousness followed by true resting tremor and
eventual truncal ataxia. Lack of clinical
tremor does not exclude subclinical neuro-
logic effects if evaluated with a computer-
based test method described by Netterstrom
et al. (1996). Peripheral neuropathy symp-
toms of paresthesias can also be presenting
symptoms. Decision to treat should be based
on neurologic and renal toxicity; therefore, a
neurologic examination and assessment of
serum and urine mercury, renal function, and
presence of proteinuria should be part of the
exposed patient’s evaluation. Formal psycho-
logic testing may be necessary depending on
the patient and family observations or persis-
tence of personality change or psychiatric
complaints (LaDou 1997).
Remarkably, our patients reported no pul-
monary complaints, even upon suggestive
questioning. They both manifested transient
gastrointestinal symptoms. Intern Y com-
plained of lethargy and headache but no
neurologic abnormalities were found on
examination; also, his renal function remained
normal with no proteinuria. Intern X was
reported by his mother to have a sense of
tremulousness, but his primary physician did
not observe any objective tremor or ataxia.
Transient slight elevation in serum creatinine
and subsequent normalization suggested that
he had mild renal toxicity, but no proteinuria
was noted despite the documented renal
excretion of mercury. His 24-hr excretion of
356 µg/L with a creatinine of 1.2 µg/g is
below the 500 µg/g creatinine associated with
significant renal or neurologic toxicity
(LaDou 1997).
After the cleanup, several recommenda-
tions were made to the merchant marine
(Norman 2000): a) replacement of all king
gauges with non-mercury-containing instru-
ments; b) secondary containment of mercury
instrumentation devices; c) storage of elemental
mercury in sealed containers within an air-
conditioned locker that, upon impact, cannot
allow leakage; d) training technicians in proto-
cols for filling king gauge reservoirs; and
e) availability of rubber gloves, chemical splash
goggles, and respirators with mercury vapor
cartridges for cleanup on board ship.
Training procedures for cleanup of spills
and reﬁlling of gauges were initiated, contain-
ment devices were installed, and the mercury
was thereafter stored in sealed containers in a
cooled environment. However, at present,
merchant marine ballast monitors still use
mercury, and no acceptable engineering alter-
natives have as yet been designed or installed.
Conclusion
The clinical courses of these two interns illus-
trate several important pathophysiologic prin-
ciples. Intern Y certainly had a toxic inhalation
exposure, but his symptoms quickly resolved
when the exposure ended. Intern X clearly had
more inhalation exposure because he was
working in the less-ventilated part of the stor-
age room. The door was on the other side, and
there was no other ventilation (Figure 2), but
his increasing mercury levels after the initial
exposure suggested continued exposure
(Figure 1).
Symptoms, interpreted as “nervousness”
by intern X’s mother, resolved within 4 days
of removing his boots at the time of hospitali-
zation. By the time he presented to one of us
(R.R.R.) for return to work, neurologic evalu-
ation showed no signs of ataxia or dementia.
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Computer-based tremor testing was not
performed.
Although mercury toxicity may result from
consumption of fish and from amalgam fill-
ings, the marked decrease in his serum levels
correlated with the removal of his footwear.
We are not aware of previously reported cases
of cutaneous elemental absorption leading to
toxicity. Increased inhalation is possible from
the mercury in the intern’s boots, because con-
tamination of skin and clothing has been
shown to increase the mercury in the micro-
environment (Henderson 1973). However, we
speculate that cutaneous absorption of vapor
may have been a contributing factor leading
to continued elevation of his serum mercury
levels. On the basis of the studies reviewed,
we conclude that the neurologic symptoms of
both interns resolved with the removal from
mercury exposure, storage in the renal com-
partment, and physiologic mercury excretion,
although chelation was initiated in the more
severely affected intern.
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